Randomized Trial of a Smoking Cessation Program for Persons with SMI

SMI 患者戒烟计划的随机试验

• 批准号: 7786750
• 负责人: LISA B. DIXON
• 金额: --
• 依托单位: BALTIMORE VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-10-01 至 2013-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7786750
• 关键词: Abstinence; Address; Aftercare; American Lung Association; Attention; Behavior Therapy; Behavioral; Biological; Bupropion; Carbon Monoxide; Categories; Cessation of life; Characteristics; Cigarette; Clinic; Clinical Practice Guideline; Cocaine; Cognitive; Communities; Department of Defense; Diabetes Mellitus; Diagnostic; Disabled Persons; Disease; Drug usage; Education; Effectiveness; Ensure; Face; Funding; General Population; Goals; Grant; Guidelines; Health; Health Care Costs; Health care facility; Healthcare; Healthcare Systems; Heart Diseases; Heroin; Impairment; Intervention; Life; Malignant neoplasm of lung; Maryland; Measures; Medical Economics; Mental Health; Mental disorders; Modeling; Morbidity - disease rate; National Institute of Drug Abuse; Nicotine Dependence; Obesity; Outcome; Participant; Patient Self-Report; Patients; Persons; Pharmacotherapy; Phase; Policies; Population; Procedures; Public Health; Randomized; Randomized Clinical Trials; Readiness; Recruitment Activity; Reporting; Research; Schizophrenia; Series; Severities; Smoke; Smoker; Smoking; Smoking Cessation Intervention; Social support; Specific qualifier value; Substance Addiction; Substance Use Disorder; Substance abuse problem; Technology; Testing; Tobacco use; United States; United States Agency for Healthcare Research and Quality; Veterans; Withholding Treatment; Work; abstracting; addiction; base; cigarette smoking; contingency management; cost; design; evidence base; follow-up; handicapping condition; health care quality; improved; innovation; meetings; mortality; nicotine replacement; novel strategies; outreach; programs; psychologic; public health relevance; randomized trial; smoking cessation; social; social model; substance abuser; therapy development; tool; treatment program; trial comparing

DESCRIPTION (provided by applicant): Abstract Over 70% of people with serious and persistent mental illnesses (SPMI) smoke cigarettes. We have found that delivery of the 5 As of smoking cessation (Ask, Advise, Assess, Assist, Arrange) to persons with SPMI, a practice required by the VA, produces modest reductions in smoking and some increased use of smoking cessation aids, but does not increase abstinence. Existing "best practices" for smoking cessation in SPMI produce low short-term abstinence rates and almost no sustained abstinence. A new approach is needed that is designed for persons with SPMI and utilizes all available strategies for addiction treatment. We have developed an intervention called "Behavioral Treatment of Smoking Cessation in SPMI" (BTSCS), an innovative program that supplements pharmacotherapy and education with contingency management and a multifaceted behavioral group treatment that addresses the cognitive, motivational, and social support problems characteristic of people with SPMI. We propose to conduct a randomized trial of BTSCS compared to a manualized standard cessation program (StSST) that reflects current best practices. BTSCS was modeled after a successful program (Behavioral Treatment of Substance Abuse in SPMI) created by the study team that was designed for people with dual disorders. Hypotheses: We hypothesize that BTSCS will be more effective than StSST in producing and sustaining abstinence as measured by self report and expired CO levels. Subject Population: We will recruit 210 people with SPMI who smoke at least 10 cigarettes per day from the VA Maryland Healthcare System. We expect to randomize 178 people. Procedures: Participants in both conditions will receive brief outreach. Research assessments will be completed at baseline, 3 months (end of treatment), and 3- and 6- month follow ups. Potential Impact on Veterans' Health Care: The VA has recognized the high medical, economic, and social costs of smoking with directives to ensure that veterans are offered cessation programs. Testing an innovative smoking cessation treatment for persons with SPMI is highly significant for the VA because: (1) the rates of smoking among veterans are higher that the general population; (2) smoking rates among persons with SPMI are higher still, and; (3) there are virtually no smoking cessation treatments for veterans with SPMI that are effective in producing abstinence. PUBLIC HEALTH RELEVANCE: Project Narrative Despite widespread recognition of the devastating health effects of smoking and the extraordinarily high rates of smoking in people SMI, smoking in SMI has not received the full and urgent attention that it deserves. Given the elevated rates of smoking among patients with SMI, our efforts to test an innovative, broad-based smoking cessation program that is tailored to the needs of this multi-handicapped population carry significant cost, health, and quality of care implications. Integration of smoking cessation within the context of mental health treatment will also provide a new context for addressing nicotine addiction, further enhancing the public health significance of the research.

描述（由申请人提供）：